Preparing for the impact of ESG policies on market access in Europe
With growing regulatory pressure in Europe, including the EU’s commitment to carbon neutrality by 2050, environmental sustainability is becoming an important consideration for pharmaceutical companies seeking long-term market success. This, coupled with a rising focus on social responsibility and ethical governance has placed environmental, social and governance (ESG) factors […] Click here to view original […]
Preparing for the impact of ESG policies on market access in Europe Read More »





